Literature DB >> 1927939

Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina.

K Matsuyama1, H Yasue, K Okumura, Y Saito, K Nakao, G Shirakami, H Imura.   

Abstract

To examine the role of endothelin in coronary spasm, the plasma endothelin-1-like immunoreactivity in the coronary sinus and the aortic root was measured before and during spasm of the left coronary artery induced by injection of acetylcholine (20 to 100 micrograms) into the left coronary artery in 26 patients with coronary spastic angina. The plasma level of endothelin-1-like immunoreactivity was measured by the radioimmunoassay with a monoclonal antibody against endothelin-1. Plasma lactate levels in the coronary sinus and the aortic root were also measured to evaluate myocardial lactate metabolism during spasm. In 13 patients who had myocardial lactate production during spasm, the plasma level of endothelin-1-like immunoreactivity in the coronary sinus increased from 19.8 +/- 3.0 to 25.7 +/- 6.4 pg/ml (p less than 0.01), while that in the aortic root remained unchanged (from 20.2 +/- 5.9 to 21.3 +/- 5.8 pg/ml). No significant changes in the plasma levels of endothelin-1-like immunoreactivity in the coronary sinus (from 21.1 +/- 7.3 to 19.7 +/- 5.2 pg/ml) and the aortic root (from 21.1 +/- 5.7 to 19.7 +/- 5.6 pg/ml) were observed in 13 patients who did not show myocardial lactate production during spasm. On the other hand, 16 patients without ischemic heart disease showed no significant changes in the plasma levels of endothelin-1-like immunoreactivity in the coronary sinus (from 24.4 +/- 9.7 to 25.8 +/- 6.9 pg/ml) and the aortic root (from 23.0 +/- 7.1 to 23.4 +/- 5.8 pg/ml) by acetylcholine injection (100 micrograms).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1927939     DOI: 10.1016/0002-9149(91)90484-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

2.  Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor.

Authors:  C Zouki; C Baron; A Fournier; J G Filep
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  Endothelin-1 activates a Ca2+-permeable cation channel with TRPC3 and TRPC7 properties in rabbit coronary artery myocytes.

Authors:  C M Peppiatt-Wildman; A P Albert; S N Saleh; W A Large
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

4.  Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion.

Authors:  G F Skovsted; L S Kruse; R Larsen; A F Pedersen; S Trautner; M Sheykhzade; L Edvinsson
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

5.  Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.

Authors:  J G Filep; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

6.  Endothelin-1 in patients with complicated and uncomplicated myocardial infarction.

Authors:  P Lechleitner; N Genser; J Mair; J Maier; E Artner-Dworzak; F Dienstl; B Puschendorf
Journal:  Clin Investig       Date:  1992-12

Review 7.  Endothelin and myocardial ischemia.

Authors:  D Hasdai; R Kornowski; A Battler
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

8.  Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.

Authors:  M G Peter; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

9.  Takotsubo Syndrome: Clinical Manifestations, Etiology and Pathogenesis.

Authors:  Ekaterina S Prokudina; Boris K Kurbatov; Konstantin V Zavadovsky; Alexander V Vrublevsky; Natalia V Naryzhnaya; Yuri B Lishmanov; Leonid N Maslov; Peter R Oeltgen
Journal:  Curr Cardiol Rev       Date:  2021

10.  Endothelin-1 and norepinephrine overflow from cardiac sympathetic nerve endings in myocardial ischemia.

Authors:  Masashi Tawa; Satoshi Yamamoto; Mamoru Ohkita; Yasuo Matsumura
Journal:  Cardiol Res Pract       Date:  2012-06-25       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.